Meadows et al. showed that the level of GDF-15 in the plasma of PAH patients with systemic sclerosis (SSc) is significantly higher than that of SSc patients without pulmonary arterial hypertension (17). The gene discussed is GDF15; the disease is pulmonary arterial hypertension.